Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.1750
+0.0140 (8.70%)
Mar 13, 2026, 1:11 PM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $808.65 thousand as of March 16, 2026. Its market cap has decreased by -85.62% in one year.
Market Cap
808.65K
Enterprise Value
-783.04K
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.18
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 808.65K, a decrease of -97.01%. That is a compound annual growth rate of -66.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 808.65K | -2.78% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eastgate Biotech | 1.06M |
| Exousia Pro | 1.05M |
| Scorpius Holdings | 1.04M |
| Emmaus Life Sciences | 1.02M |
| Protagenic Therapeutics | 887.18K |
| EV Biologics | 848.71K |
| THC Farmaceuticals | 834.05K |
| Avenue Therapeutics | 757.77K |